Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 178

1.

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry.

Birndt S, Schenk T, Heinevetter B, Brunkhorst FM, Maschmeyer G, Rothmann F, Weber T, Müller M, Panse J, Penack O, Schroers R, Braess J, Frickhofen N, Ehl S, Janka G, Lehmberg K, Pletz MW, Hochhaus A, Ernst T, La Rosée P.

J Cancer Res Clin Oncol. 2020 Feb 20. doi: 10.1007/s00432-020-03139-4. [Epub ahead of print]

PMID:
32076823
2.

Antimicrobial stewardship in patients with acute bacterial skin and skin structures infections: an international Delphi consensus.

Soriano A, Stefani S, Pletz MW, Menichetti F; Italian Group for Antimicrobial Stewardship (GISA).

J Glob Antimicrob Resist. 2020 Feb 14. pii: S2213-7165(20)30031-X. doi: 10.1016/j.jgar.2020.02.002. [Epub ahead of print] Review.

3.

Hospital-wide ELectronic medical record evaluated computerised decision support system to improve outcomes of Patients with staphylococcal bloodstream infection (HELP): study protocol for a multicentre stepped-wedge cluster randomised trial.

Hagel S, Gantner J, Spreckelsen C, Fischer C, Ammon D, Saleh K, Phan-Vogtmann LA, Heidel A, Müller S, Helhorn A, Kruse H, Thomas E, Rißner F, Haferkamp S, Vorwerk J, Deffge S, Juzek-Küpper MF, Lippmann N, Lübbert C, Trawinski H, Wendt S, Wendt T, Dürschmid A, Konik M, Moritz S, Tiller D, Röhrig R, Schulte-Coerne J, Fortmann J, Jonas S, Witzke O, Rath PM, Pletz MW, Scherag A.

BMJ Open. 2020 Feb 10;10(2):e033391. doi: 10.1136/bmjopen-2019-033391.

4.

Changes in inflammatory and vasoactive mediator profiles during valvular surgery with or without infective endocarditis: A case control pilot study.

Diab M, Tasar R, Sponholz C, Lehmann T, Pletz MW, Bauer M, Brunkhorst FM, Doenst T.

PLoS One. 2020 Feb 3;15(2):e0228286. doi: 10.1371/journal.pone.0228286. eCollection 2020.

5.

Staphylococcus aureus Pneumonia: Preceding Influenza Infection Paves the Way for Low-Virulent Strains.

Deinhardt-Emmer S, Haupt KF, Garcia-Moreno M, Geraci J, Forstner C, Pletz M, Ehrhardt C, Löffler B.

Toxins (Basel). 2019 Dec 17;11(12). pii: E734. doi: 10.3390/toxins11120734.

6.

Clinically Approved Drugs Inhibit the Staphylococcus aureus Multidrug NorA Efflux Pump and Reduce Biofilm Formation.

Zimmermann S, Klinger-Strobel M, Bohnert JA, Wendler S, Rödel J, Pletz MW, Löffler B, Tuchscherr L.

Front Microbiol. 2019 Dec 3;10:2762. doi: 10.3389/fmicb.2019.02762. eCollection 2019.

7.

Highly Sensitive Detection of the Antibiotic Ciprofloxacin by Means of Fiber Enhanced Raman Spectroscopy.

Wolf S, Frosch T, Popp J, Pletz MW, Frosch T.

Molecules. 2019 Dec 10;24(24). pii: E4512. doi: 10.3390/molecules24244512.

8.

Intestinal colonization with extended-spectrum beta-lactamase producing Enterobacterales (ESBL-PE) during long distance travel: A cohort study in a German travel clinic (2016-2017).

Meurs L, Lempp FS, Lippmann N, Trawinski H, Rodloff AC, Eckardt M, Klingeberg A, Eckmanns T, Walter J, Lübbert C; Rai Study group.

Travel Med Infect Dis. 2020 Jan - Feb;33:101521. doi: 10.1016/j.tmaid.2019.101521. Epub 2019 Nov 23.

PMID:
31770602
9.

Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia.

Forstner C, Kolditz M, Kesselmeier M, Ewig S, Rohde G, Barten-Neiner G, Rupp J, Witzenrath M, Welte T, Pletz MW; CAPNETZ study group.

Vaccine. 2020 Jan 29;38(5):1129-1136. doi: 10.1016/j.vaccine.2019.11.026. Epub 2019 Nov 21.

PMID:
31761500
10.

Rate and Predictors of Bacteremia in Afebrile Community-Acquired Pneumonia.

Forstner C, Patchev V, Rohde G, Rupp J, Witzenrath M, Welte T, Burgmann H, Pletz MW; CAPNETZ Study Group.

Chest. 2019 Oct 26. pii: S0012-3692(19)34102-9. doi: 10.1016/j.chest.2019.10.006. [Epub ahead of print]

PMID:
31669433
11.

Reply to Theilacker et al.

Kolditz M, Schmitt J, Pletz MW, Tesch F.

Clin Infect Dis. 2019 Sep 7. pii: ciz883. doi: 10.1093/cid/ciz883. [Epub ahead of print] No abstract available.

PMID:
31624832
12.

Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learning.

König R, Cao X, Oswald M, Forstner C, Rohde G, Rupp J, Witzenrath M, Welte T, Kolditz M, Pletz M; CAPNETZ study group.

Eur Respir J. 2019 Dec 12;54(6). pii: 1900824. doi: 10.1183/13993003.00824-2019. Print 2019 Dec.

PMID:
31537702
13.

MBEC Versus MBIC: the Lack of Differentiation between Biofilm Reducing and Inhibitory Effects as a Current Problem in Biofilm Methodology.

Thieme L, Hartung A, Tramm K, Klinger-Strobel M, Jandt KD, Makarewicz O, Pletz MW.

Biol Proced Online. 2019 Sep 13;21:18. doi: 10.1186/s12575-019-0106-0. eCollection 2019.

14.

Carbapenem-resistant Klebsiella pneumoniae with low chlorhexidine susceptibility.

Stein C, Vincze S, Kipp F, Makarewicz O, Al Dahouk S, Pletz MW.

Lancet Infect Dis. 2019 Sep;19(9):932-933. doi: 10.1016/S1473-3099(19)30427-X. No abstract available.

PMID:
31478517
15.

Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia.

Villafuerte D, Aliberti S, Soni NJ, Faverio P, Marcos PJ, Wunderink RG, Rodriguez A, Sibila O, Sanz F, Martin-Loeches I, Menzella F, Reyes LF, Jankovic M, Spielmanns M, Restrepo MI; GLIMP Investigators.

Respirology. 2019 Aug 5. doi: 10.1111/resp.13663. [Epub ahead of print]

PMID:
31385399
16.

Assessing genetic diversity and similarity of 435 KPC-carrying plasmids.

Brandt C, Viehweger A, Singh A, Pletz MW, Wibberg D, Kalinowski J, Lerch S, Müller B, Makarewicz O.

Sci Rep. 2019 Aug 2;9(1):11223. doi: 10.1038/s41598-019-47758-5.

17.

[Vaccination of the immunocompromised patient].

Jablonka A, Rößler S, Pletz MW, Schleenvoigt BT.

MMW Fortschr Med. 2019 Jul;161(13):56-60. doi: 10.1007/s15006-019-0715-1. Review. German. No abstract available.

PMID:
31313172
18.

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients.

Di Pasquale MF, Sotgiu G, Gramegna A, Radovanovic D, Terraneo S, Reyes LF, Rupp J, González Del Castillo J, Blasi F, Aliberti S, Restrepo MI; GLIMP Investigators.

Clin Infect Dis. 2019 Apr 24;68(9):1482-1493. doi: 10.1093/cid/ciy723.

19.

PCR-based routine diagnostics uncover hidden burden of Legionnaires' disease.

Pletz MW, Ewig S, Welte T.

Lancet Infect Dis. 2019 Jul;19(7):681-683. doi: 10.1016/S1473-3099(19)30171-9. Epub 2019 Jun 10. No abstract available.

PMID:
31196814
20.

Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.

Hagel S, Fiedler S, Hohn A, Brinkmann A, Frey OR, Hoyer H, Schlattmann P, Kiehntopf M, Roberts JA, Pletz MW; TARGET Study Group.

Trials. 2019 Jun 6;20(1):330. doi: 10.1186/s13063-019-3437-x.

Supplemental Content

Loading ...
Support Center